Cytokines as a stressor: implications for depressive illness (original) (raw)

Journal Article

,

Institute of Neuroscience, Carleton University, Ottawa, Ontario, Canada

Address for correspondence: Dr H. Anisman, Life Science Research Building, Carleton University, Ottawa, Ontario K1S 5B6, Canada. Tel.: (613) 520-2699_Fax_:

(613) 520-4052

E-mail: hanisman@ccs.carleton.ca

Search for other works by this author on:

,

Institute of Neuroscience, Carleton University, Ottawa, Ontario, Canada

Search for other works by this author on:

,

Institute of Neuroscience, Carleton University, Ottawa, Ontario, Canada

Search for other works by this author on:

School of Psychology and Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada

Search for other works by this author on:

Received:

09 December 2001

Revision received:

28 April 2002

Published:

01 December 2002

Cite

Hymie Anisman, Shawn Hayley, Nicolas Turrin, Zul Merali, Cytokines as a stressor: implications for depressive illness, International Journal of Neuropsychopharmacology, Volume 5, Issue 4, December 2002, Pages 357–373, https://doi.org/10.1017/S1461145702003097
Close

Navbar Search Filter Mobile Enter search term Search

Abstract

Stressful events have been implicated in the provocation of depressive illness. Inasmuch as immunological challenge, and particularly cytokine administration, engender neuroendocrine and central neurochemical changes reminiscent of those provoked by psychogenic stressors, it was suggested that immune activation may also contribute to affective illness. The present report provides a brief overview of the neurochemical sequelae of acute and repeated interleukin-1β (IL-1β), tumour necrosis factor-α (TNF-α) and IL-2 treatment, describes some of the synergisms associated with these treatments, as well as their potential interactions with psychogenic stressors. In addition, a discussion is provided concerning the fact that cytokines, like stressors, may have time-dependent proactive effects, so that re-exposure to the treatments provoke greatly augmented neurochemical changes (sensitization). Given that the effects of cytokines are evident within hypothalamic, as well as extrahypothalamic sites, including various limbic regions, it is suggested that cytokines may impact on emotional changes, including depression.

This content is only available as a PDF.

© 2002 Collegium Internationale Neuropsychopharmacologicum

Topic:

Citations

Views

Altmetric

Metrics

Total Views 685

90 Pageviews

595 PDF Downloads

Since 1/1/2017

Month: Total Views:
January 2017 4
February 2017 7
March 2017 4
April 2017 8
May 2017 4
June 2017 2
July 2017 4
August 2017 6
September 2017 9
October 2017 7
November 2017 7
December 2017 20
January 2018 13
February 2018 7
March 2018 26
April 2018 15
May 2018 4
June 2018 7
July 2018 11
August 2018 8
September 2018 10
October 2018 6
November 2018 5
December 2018 3
January 2019 5
February 2019 6
March 2019 9
April 2019 10
May 2019 11
June 2019 6
July 2019 10
August 2019 8
September 2019 10
October 2019 3
November 2019 10
December 2019 8
January 2020 3
February 2020 7
March 2020 8
April 2020 5
May 2020 2
June 2020 11
July 2020 8
August 2020 4
September 2020 5
October 2020 8
November 2020 11
December 2020 5
January 2021 5
February 2021 4
March 2021 9
April 2021 8
May 2021 7
June 2021 2
July 2021 8
August 2021 9
September 2021 6
October 2021 9
November 2021 9
December 2021 5
January 2022 3
February 2022 7
March 2022 8
April 2022 8
May 2022 11
June 2022 5
July 2022 5
August 2022 1
September 2022 8
October 2022 4
November 2022 9
December 2022 5
January 2023 6
February 2023 10
March 2023 4
April 2023 5
May 2023 13
June 2023 6
July 2023 1
August 2023 6
September 2023 9
October 2023 9
November 2023 7
December 2023 8
January 2024 9
February 2024 13
March 2024 11
April 2024 15
May 2024 6
June 2024 5
July 2024 5
August 2024 5
September 2024 2
October 2024 5

Citations

85 Web of Science

×

Email alerts

Citing articles via

More from Oxford Academic